The Arab Drug Company (EGX:ADCI)
Egypt · Delayed Price · Currency is EGP 160.48
+1.79 (1.13%)
At close: Feb 2, 2026
The Arab Drug Company Revenue
The Arab Drug Company had revenue of 306.02M EGP in the quarter ending September 30, 2025, with 31.16% growth. This brings the company's revenue in the last twelve months to 1.19B, up 43.89% year-over-year. In the fiscal year ending June 30, 2025, The Arab Drug Company had annual revenue of 1.12B with 42.35% growth.
Revenue (ttm)
1.19B
Revenue Growth
+43.89%
P/S Ratio
1.62
Revenue / Employee
1.04M
Employees
1,148
Market Cap
1.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.12B | 332.65M | 42.35% |
| Jun 30, 2024 | 785.52M | 151.79M | 23.95% |
| Jun 30, 2023 | 633.73M | 128.69M | 25.48% |
| Jun 30, 2022 | 505.04M | -32.01M | -5.96% |
| Jun 30, 2021 | 537.05M | 16.25M | 3.12% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition